Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen J Kent

Showing results (1-10 of 390) with videos related to

Pageof 39
Sort By:
The Journal of Infectious Diseases|October 22, 2013
Toward improved influenza vaccinesStephen J Kent
The Lancet. HIV|October 2, 2015
Trying to cure HIV with immunotherapy: not so simpleStephen J Kent
AIDS Research and Human Retroviruses|January 28, 2012
Loss of control of HIV viremia associated with the fat malabsorption drug orlistatStephen J Kent
Human Vaccines|March 11, 2011
HIV Vaccine efficacy trial: glimmers of hope and the potential role of antibody-dependent cellular cytotoxicityLeia Wren, Stephen J Kent
AIDS Research and Human Retroviruses|July 16, 2008
Quantification of simian immunodeficiency virus cytotoxic T lymphocyte escape mutant virusesLiyen Loh, Stephen J Kent
Journal of Virology|September 28, 2007
Utility of human immunodeficiency virus type 1 envelope as a T-cell immunogenViv Peut, Stephen J Kent
AIDS Research and Therapy|November 27, 2018
Ageing in patients with chronic HIV infection: impact of hypercoagulationStephen J Kent, Charles Flexner
Current HIV Research|April 14, 2006
Fitness constraints on immune escape from HIV: Implications of envelope as a target for both HIV-specific T cells and antibodyViv Peut, Stephen J Kent
Virology|December 19, 2008
Substantial envelope-specific CD8 T-cell immunity fails to control SIV diseaseViv Peut, Stephen J Kent
Frontiers in Cellular and Infection Microbiology|June 9, 2020
What Can Gamma Delta T Cells Contribute to an HIV Cure?Jennifer A Juno, Stephen J Kent
Pageof 39

Showing results (1-10 of 390) with videos related to

Sort By:
Pageof 39
The Journal of Infectious Diseases|October 22, 2013
Toward improved influenza vaccinesStephen J Kent
The Lancet. HIV|October 2, 2015
Trying to cure HIV with immunotherapy: not so simpleStephen J Kent
AIDS Research and Human Retroviruses|January 28, 2012
Loss of control of HIV viremia associated with the fat malabsorption drug orlistatStephen J Kent
Human Vaccines|March 11, 2011
HIV Vaccine efficacy trial: glimmers of hope and the potential role of antibody-dependent cellular cytotoxicityLeia Wren, Stephen J Kent
AIDS Research and Human Retroviruses|July 16, 2008
Quantification of simian immunodeficiency virus cytotoxic T lymphocyte escape mutant virusesLiyen Loh, Stephen J Kent
Journal of Virology|September 28, 2007
Utility of human immunodeficiency virus type 1 envelope as a T-cell immunogenViv Peut, Stephen J Kent
AIDS Research and Therapy|November 27, 2018
Ageing in patients with chronic HIV infection: impact of hypercoagulationStephen J Kent, Charles Flexner
Current HIV Research|April 14, 2006
Fitness constraints on immune escape from HIV: Implications of envelope as a target for both HIV-specific T cells and antibodyViv Peut, Stephen J Kent
Virology|December 19, 2008
Substantial envelope-specific CD8 T-cell immunity fails to control SIV diseaseViv Peut, Stephen J Kent
Frontiers in Cellular and Infection Microbiology|June 9, 2020
What Can Gamma Delta T Cells Contribute to an HIV Cure?Jennifer A Juno, Stephen J Kent
Pageof 39